CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1)

Cat# USCN-SCB054Ra-96

Size : 96T

Brand : USCN

Request more information

Contact local distributor :


Phone : +1 850 650 7790
CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1)

CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1)

CED4; Apoptotic Protease Activating Factor

  • Product No.SCB054Ra
  • Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
  • Test MethodDouble-antibody Sandwich
  • Assay Length2h, 40min
  • Detection Range13.7-10,000pg/mL
  • SensitivityThe minimum detectable dose of this kit is typically less than 4.93pg/mL.
  • Sample TypeTissue homogenates and other biological fluids
  • Download Instruction Manual
  • UOM 48T96T 96T*5 96T*10 96T*100
  • CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1) Packages (Simulation)
  • CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1) Packages (Simulation)
  • CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1) Results demonstration
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1)

This assay has high sensitivity and excellent specificity for detection of Apoptotic Peptidase Activating Factor 1 (APAF1).
No significant cross-reactivity or interference between Apoptotic Peptidase Activating Factor 1 (APAF1) and analogues was observed.

Precision of the CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Apoptotic Peptidase Activating Factor 1 (APAF1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Apoptotic Peptidase Activating Factor 1 (APAF1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Stability of the CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Apoptotic Peptidase Activating Factor 1 (APAF1)

The microplate provided in this kit has been pre-coated with an antibody specific to Apoptotic Peptidase Activating Factor 1 (APAF1). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Apoptotic Peptidase Activating Factor 1 (APAF1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Apoptotic Peptidase Activating Factor 1 (APAF1) level in the sample or standard.;